{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:55:54Z","timestamp":1788616554393,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/rlu.0000000000000291","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T11:40:12Z","timestamp":1384170012000},"page":"26-31","source":"Crossref","is-referenced-by-count":34,"title":["Prospective Multicenter Study of Bone Scintigraphy in Consecutive Patients With Newly Diagnosed Prostate Cancer"],"prefix":"10.1097","volume":"39","author":[{"given":"Helle Damgaard","family":"Zacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Barsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper C.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen K.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Josephsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars J.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(08)60729-1","article-title":"Prostate cancer.","volume":"371","author":"Damber","year":"2008","journal-title":"Lancet"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djm249","article-title":"Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.","volume":"99","author":"Kvale","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R3-5-20210204","article-title":"Available at: .","year":"2013","journal-title":"Accessed May"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.6004\/jnccn.2012.0114","article-title":"Prostate cancer, version 3.2012 featured update to the NCCN Guidelines.","volume":"10","author":"Mohler","year":"2012","journal-title":"J Natl Compr Cancer Netw"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"957364","DOI":"10.1155\/2012\/957364","article-title":"Multiple metastasis-like bone lesions in scintigraphic imaging.","volume":"2012","author":"Zhang","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-5347(17)38325-8","article-title":"Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.","volume":"145","author":"Chybowski","year":"1991","journal-title":"J Urol"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0360-3016(00)00785-9","article-title":"Which patients with newly diagnosed prostate cancer need a radionuclide bone scan An analysis based on 631 patients.","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-5-20210204","first-page":"265","article-title":"Is it suitable to eliminate bone scan for prostate cancer patients with PSA 20 ngmL World J Urol.","volume":"30","author":"Lee","year":"2012","journal-title":""},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-4295(96)80016-1","article-title":"Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.","volume":"47","author":"Gleave","year":"1996","journal-title":"Urology"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1100\/tsw.2009.113","article-title":"The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.","volume":"9","author":"Ritenour","year":"2009","journal-title":"Sci World J"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.1993.03500010067033","article-title":"The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.","volume":"269","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2009.12.023","article-title":"When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.","volume":"57","author":"Briganti","year":"2010","journal-title":"Eur Urol"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.urology.2010.12.083","article-title":"Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.","volume":"77","author":"Palvolgyi","year":"2011","journal-title":"Urology"},{"key":"R16-5-20210204","article-title":"The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. Available at: .","author":"Howick","year":"2013","journal-title":"Accessed May"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12149-009-0317-6","article-title":"Impact of additional SPECT in bone scanning in tumor patients with suspected metastatic bone disease.","volume":"23","author":"Apostolova","year":"2009","journal-title":"Ann Nucl Med"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MNM.0b013e32834e3b14","article-title":"Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management.","volume":"33","author":"Sharma","year":"2012","journal-title":"Nucl Med Commun"},{"key":"R19-5-20210204","first-page":"B99","article-title":"Bone scintigraphy: procedure guidelines for tumour imaging.","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R20-5-20210204","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PETCT.","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy.","volume":"21","author":"Yang","year":"2011","journal-title":"Eur Radiol"},{"key":"R22-5-20210204","first-page":"68","article-title":"Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer Eur Urol.","volume":"62","author":"Lecouvet","year":"2012","journal-title":""},{"key":"R23-5-20210204","first-page":"374","article-title":"Diagnosis of bone metastasis: recent comparative studies of imaging modalities.","volume":"55","author":"Talbot","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R25-5-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2012.42.8375","article-title":"American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.","volume":"30","author":"Schnipper","year":"2012","journal-title":"J Clin Oncol"},{"key":"R26-5-20210204","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.urolonc.2005.09.003","article-title":"Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.","volume":"24","author":"Ryan","year":"2006","journal-title":"Urol Oncol"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.urology.2006.02.009","article-title":"Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features.","volume":"68","author":"Salonia","year":"2006","journal-title":"Urology"},{"key":"R28-5-20210204","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)67710-5","article-title":"The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.","volume":"163","author":"Albertsen","year":"2000","journal-title":"J Urol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:07:27Z","timestamp":1620972447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201401000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000291","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}